Jay Moorin, 10% Owner at AVANIR PHARMACEUTICALS (AVNR), bought 10,600 shares at $0.48 ($5K) on 2008-10-22, disclosed to the SEC on 2008-10-24.
Open-market purchase of $5k AVNR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| IMDZ | SELL | 2015-04-21 | $1.2M | — | Filing → |
| IMDZ | SELL | 2015-03-18 | $1.3M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |